AIT is the economic operator of the project „Good Good Practices in the Field of Blood Transfusion“
The AIT Austrian Institute of Technology has been awarded a contract to develop "Good Practices in the Field of Blood Transfusion" by the Consumers, Health and Food Executive Agency (CHAFEA) of the European Commission. AIT will be joined by a group of three leading experts to jointly develop an "EU Guide for Member States on Good Practices for Patient Blood Management (EU-PBM)". http://www.pressetext.com/news/20140321006
Here is a link to the offical EU-project description from the Austrian Institut of Technology AIT
http://lisavienna.at/en/news/ait-european-patient-blood-management-pbm-project-started
Definition and Rationale of Patient Blood Management PBM is a multidisciplinary concept that primarily focuses on patient safety by (1) consequently avoiding and/or treating anaemia, (2) minimising blood loss and bleeding and (3) optimising the physiological reserve of anaemia. Studies have shown that this comprehensive strategy significantly minimises the use of allogeneic blood products and therefore reduces their adverse effects on patient outcome. It has also been demonstrated that PBM saves costs for health care systems.
The main objectives of the project are
1st to study and map blood use for different medical specialities,2nd to identify and describe regional and national differences in blood utilisation and PBM strategies,
3rd to identify good practices in PBM and
4th to develop an EU guide on good practices for PBM.
This guide, which targets healthcare professionals, has to be applicable in different hospital settings and to include an evaluation strategy by using key indicators.
The project team is led by Prof. Dr. Hans Gombotz, Head of the Department of Anaesthesiology and Intensive Care at the General Hospital in Linz, Austria. He has been a pioneer in developing the PBM concept over the past decade, including two ground breaking studies on the practice of blood transfusion in Austria.
Since AIT, with its leading experts Dr. Günter Schreier and Peter Kastner, already served as a Contract Research Organisation in these two preceding projects it is also in a good position to serve as the prime contractor in the EU PBM project, taking responsibility for project and information management as well as biostatistics.
Further members of the core project team are Prof. Dr. Dr. Kai Zacharowski, FRCA, (Department of Anesthesiology and Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt) and Dr. Axel Hofmann (Department of Anesthesiology, University Hospital Zürich and School of Surgery, University of Western Australia).
EU-Contract Details : Tender report showing contract has been awarded on 27.11.2013.
http://ted.europa.eu/udl?uri=TED:NOTICE:5706-2014:TEXT:EN:HTML
Oviously the project runs since 3/2014 30 months until this year. PERTHNEWS reported about the project too. Estimated project costs about € 300,000 10 % of the Australian sum.
Under the 30-month EU contract, AIT has to develop pilot programs in five teaching hospitals, each with a minimum of 750 beds, that have “no or moderate’’ implementation of PBM. Initially, the project team must do a “baseline evaluation’’ of patient outcomes and transfusion risk and blood use at each hospital.
The team also has to do an overall evaluation of the pilots after a year, analysing the strengths and weaknesses of the program.
Eu Joint Action No 676969 under EU Health Programme
Joint Action Vigiliance and Inspection for the Safety of Transfusion started 2015. € 2. 328.664.-
http://ec.europa.eu/chafea/projects/database.html?prjno=676969